Compare · EVH vs IT
EVH vs IT
Side-by-side comparison of Evolent Health Inc (EVH) and Gartner Inc. (IT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EVH and IT operate in Other Consumer Services (Consumer Discretionary), so they compete in similar markets.
- IT is the larger of the two at $9.39B, about 14.4x EVH ($653.5M).
- Over the past year, EVH is down 40.4% and IT is down 60.3% - EVH leads by 19.9 points.
- IT has been more active in the news (15 items in the past 4 weeks vs 6 for EVH).
- IT has more recent analyst coverage (25 ratings vs 20 for EVH).
- Company
- Evolent Health Inc
- Gartner Inc.
- Price
- $5.81+2.47%
- $140.08-1.90%
- Market cap
- $653.5M
- $9.39B
- 1M return
- +23.35%
- -1.52%
- 1Y return
- -40.44%
- -60.32%
- Industry
- Other Consumer Services
- Other Consumer Services
- Exchange
- NYSE
- NYSE
- IPO
- 2015
- 1993
- News (4w)
- 6
- 15
- Recent ratings
- 20
- 25
Evolent Health Inc
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Gartner Inc.
Gartner, Inc. operates as a research and advisory company in the United States, Canada, Europe, the Middle East, Africa, and internationally. It operates through three segments: Research, Conferences, and Consulting. The Research segment offers objective insights and advice on the priorities of various leaders in a range of functional areas of the enterprise through reports, briefings, proprietary tools, access to research expert, peer networking services, and membership programs that enable clients to drive organizational performance. This segment delivers its research primarily through a subscription service. The Conferences segment offers business professionals in an organization the opportunity to learn, share, and network. The Consulting segment offers market research, custom analysis, and on-the-ground support services. This segment also offers actionable solutions for IT-related priorities, including IT cost optimization, digital transformation, and IT sourcing optimization. Gartner, Inc. was founded in 1979 and is headquartered in Stamford, Connecticut.
Latest EVH
- Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
- Chief Executive Officer Blackley Seth was granted 446,102 shares and covered exercise/tax liability with 10,297 shares, increasing direct ownership by 52% to 1,272,767 units (SEC Form 4) (tax liability)
- General Counsel Weinberg Jonathan was granted 43,055 shares and covered exercise/tax liability with 2,650 shares, increasing direct ownership by 17% to 284,917 units (SEC Form 4) to satisfy tax liability
- PRESIDENT Mccarthy Daniel Joseph was granted 302,585 shares and covered exercise/tax liability with 4,582 shares, increasing direct ownership by 70% to 721,025 units (SEC Form 4) to cover withholding tax
- Chief Accounting Officer Shams Aammaad was granted 28,790 shares, increasing direct ownership by 43% to 95,637 units (SEC Form 4)
- Evolent Health downgraded by Truist with a new price target
- SEC Form S-8 filed by Evolent Health Inc
- Director Ajayi Toyin was granted 41,096 shares, increasing direct ownership by 121% to 75,170 units (SEC Form 4)
- Director Glass Russell Monroe was granted 41,096 shares, increasing direct ownership by 113% to 77,347 units (SEC Form 4)
- Director Grua Peter J was granted 41,096 shares, increasing direct ownership by 187% to 63,075 units (SEC Form 4)
Latest IT
- Gartner Announces the Gartner Enterprise Risk, Audit & Compliance Conference 2026 in Grapevine
- Gartner Announces Gartner IT Symposium/Xpo, October 19-22, in Orlando
- SEC Form 4 filed by Director Dykstra Karen E
- SEC Form 4 filed by Director Serra Eileen
- SEC Form 4 filed by Director Rus Daniela L
- Director Pagliuca Stephen G acquired 187 shares, increasing direct ownership by 0.17% to 112,602 units (SEC Form 4)
- Director Gutierrez Jose M acquired 112 shares, increasing direct ownership by 4% to 2,951 units (SEC Form 4)
- Director Grabe William O acquired 182 shares, increasing direct ownership by 17% to 1,224 units (SEC Form 4)
- Director Fuchs Anne Sutherland acquired 100 shares, increasing direct ownership by 1% to 8,957 units (SEC Form 4)
- Director Ferguson Diana Sue acquired 201 shares, increasing direct ownership by 8% to 2,807 units (SEC Form 4)